Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ATP-sensitive inward rectifier potassium channel (KATP) in pancreatic beta cells is a hetero-octameric protein complex consisting of four pore-forming Kir6.2 subunits (encoded by KCNJ11) and four regulatory sulfonylurea receptor 1 (SUR1) subunits (encoded by ABCC8) [1, 2]. This channel serves as a critical metabolic sensor that couples the intracellular ATP/ADP ratio to the cell's membrane potential [3]. Under high glucose conditions, increased ATP production leads to channel closure, resulting in membrane depolarization, calcium influx, and the subsequent secretion of insulin [2, 4]. Genetic mutations in the KATP channel subunits are primary causes of neonatal diabetes mellitus and congenital hyperinsulinism [5]. The channel is the primary therapeutic target for sulfonylureas and meglitinides, which promote insulin release in type 2 diabetes by inducing channel closure [6]. Conversely, KATP channel openers like diazoxide are utilized to inhibit excessive insulin secretion in hypoglycemic disorders [1].
Sulfonylureas and meglitinides bind to the SUR1 subunit of the KATP channel, causing it to close; this leads to membrane depolarization, activation of voltage-gated calcium channels, and insulin exocytosis. KATP channel openers like diazoxide maintain the channel in an open state, hyperpolarizing the cell and inhibiting insulin release.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-sensitive inward rectifier potassium channel (KATP) (KATP).